NASH registry study aims to map disease in chinese patients
NCT ID NCT06123858
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This study was designed to collect information about Chinese patients with nonalcoholic steatohepatitis (NASH) and liver fibrosis. Researchers planned to track how the disease is diagnosed and treated in real-world clinics, and to understand patients' knowledge and beliefs about NASH. The study was terminated, so results may be limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASH WITH FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Beijing, China
-
Research Site
Changchun, China
-
Research Site
Chengdu, China
-
Research Site
Fuzhou, China
-
Research Site
Guangzhou, China
-
Research Site
Hangzhou, China
-
Research Site
Inner Mongolia, China
-
Research Site
Nanchang, China
-
Research Site
Qingdao, China
-
Research Site
Shanghai, China
-
Research Site
Shenyang, China
-
Research Site
Taiyuan, China
-
Research Site
Tianjin, China
-
Research Site
Wenzhou, China
-
Research Site
Xi'an, China
-
Research Site
Zhengzhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.